门诊用药不良事件混合方法分析
最常见药物类别为抗凝药(97例,46%)、抗生素(24例,11%)、降糖药(19例,9%)和阿片类(17例,8%)。结论提示门诊处方医生和社区药师可针对这些药物采取措施减少伤害。
要点
- 抗凝药相关事件最常见,占46%,需加强INR随访。
- 抗生素事件多与处方错误和未审查禁忌症有关。
- 阿片类事件常涉及与苯二氮䓬类的药物相互作用。
核心结论
- 门诊处方医生和社区药师有可能减轻抗凝药、抗生素、降糖药和阿片类相关伤害。
主要发现
- 抗凝药涉及97例(46%),抗生素24例(11%),降糖药19例(9%),阿片类17例(8%)。
- 抗凝药报告中,症状出现前已对 supratherapeutic INR 值进行及时随访。
- 抗生素报告常描述处方错误和未审查临床禁忌症。
- 降糖药报告描述因缺乏患者教育或沟通导致的低血糖事件。
- 阿片类报告描述药物相互作用,常涉及苯二氮䓬类。
临床怎么用
- 增加对 subtherapeutic INR 的随访。
- 改进抗生素处方的医疗记录整合和病历审查。
- 加强降糖药的患者教育。
- 设置警报以阻止阿片类与苯二氮䓬类的共同处方。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize ambulatory care adverse drug events reported to the Collaborative Healthcare Patient Safety Organization (CHPSO), a network of 400 hospitals across the United States, and identify addressable contributing factors. METHODS: We abstracted deidentified ambulatory care CHPSO reports compiled from May 2012 to October 2018 that included medication-related adverse events to identify implicated medications and contributing factors. We dual-coded 20% of the sample. We quantitatively calculated co-occurring frequent item sets of contributing factors and then applied a qualitative thematic analysis of co-occurring sets of contributing factors for each drug class using an inductive analytic approach to develop formal themes. RESULTS: Of 1,244 events in the sample, 208 were medication related. The most commonly implicated medication classes were anticoagulants (n = 97, or 46% of events), antibiotics (n = 24, 11%), hypoglycemics (n = 19, 9%), and opioids (n = 17, 8%). For anticoagulants, timely follow-up on supratherapeutic international normalized ratio (INR) values occurred before the development of symptoms. Incident reports citing antibiotics often described prescribing errors and failure to review clinical contraindications. Reports citing hypoglycemic drugs described low blood sugar events due to a lack of patient education or communication. Reports citing opioids described drug-drug interactions, commonly involving benzodiazepines. CONCLUSION: Ambulatory care prescribing clinicians and community pharmacists have the potential to mitigate harm related to anticoagulants, antibiotics, hypoglycemics, and opioids. Recommendations include increased follow-up for subtherapeutic INRs, improved medical record integration and chart review for antibiotic prescriptions, enhanced patient education regarding hypoglycemics, and alerts to dissuade coprescription of opioids and benzodiazepines.
引用
- Wong J, Lee SY, Sarkar U, et al. Medication adverse events in the ambulatory setting: A mixed-methods analysis. Am J Health Syst Pharm. 2022. PMID: 36164846. doi:10.1093/ajhp/zxac253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。